RU97113248A - IMPROVED MEDICINAL FORM OF HUMAN CANDLE INTERFERON - Google Patents
IMPROVED MEDICINAL FORM OF HUMAN CANDLE INTERFERONInfo
- Publication number
- RU97113248A RU97113248A RU97113248/14A RU97113248A RU97113248A RU 97113248 A RU97113248 A RU 97113248A RU 97113248/14 A RU97113248/14 A RU 97113248/14A RU 97113248 A RU97113248 A RU 97113248A RU 97113248 A RU97113248 A RU 97113248A
- Authority
- RU
- Russia
- Prior art keywords
- human
- candle
- interferon
- vitamin
- medicinal form
- Prior art date
Links
- 108010050904 Interferons Proteins 0.000 title claims 2
- 102000014150 Interferons Human genes 0.000 title claims 2
- 229940079322 interferon Drugs 0.000 title claims 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims 4
- 102100008763 IFNA2 Human genes 0.000 claims 2
- 108010078049 Interferon alpha-2 Proteins 0.000 claims 2
- 229940045997 Vitamin A Drugs 0.000 claims 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims 2
- 229930003268 Vitamin C Natural products 0.000 claims 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims 2
- 229940087168 alpha Tocopherol Drugs 0.000 claims 2
- 229940110456 cocoa butter Drugs 0.000 claims 2
- 235000019868 cocoa butter Nutrition 0.000 claims 2
- 229920002674 hyaluronan Polymers 0.000 claims 2
- 229960003160 hyaluronic acid Drugs 0.000 claims 2
- 229960003471 retinol Drugs 0.000 claims 2
- MAKUBRYLFHZREJ-JWBQXVCJSA-M sodium;(2S,3S,4R,5R,6R)-3-[(2S,3R,5S,6R)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylate Chemical compound [Na+].CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@H](O)[C@H]1O MAKUBRYLFHZREJ-JWBQXVCJSA-M 0.000 claims 2
- 229960000984 tocofersolan Drugs 0.000 claims 2
- 235000019155 vitamin A Nutrition 0.000 claims 2
- 239000011719 vitamin A Substances 0.000 claims 2
- 235000019154 vitamin C Nutrition 0.000 claims 2
- 239000011718 vitamin C Substances 0.000 claims 2
- 150000003700 vitamin C derivatives Chemical class 0.000 claims 2
- 239000002076 α-tocopherol Substances 0.000 claims 2
- 235000004835 α-tocopherol Nutrition 0.000 claims 2
- 230000000111 anti-oxidant Effects 0.000 claims 1
- 239000003963 antioxidant agent Substances 0.000 claims 1
- 235000006708 antioxidants Nutrition 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
Claims (1)
Рекомбинантный человеческий интерферон альфа-2 - (7,0 - 17,5) • 106 МЕ
α-Токоферол - 3,5 - 7,0
Витамин С - 0,7 - 1,4
Витамин А - 0,7 - 1,4
Гиалуроновая кислота - 1,0 - 2,0
Масло какао - До 100Candle as a dosage form of human recombinant interferon alpha-2, including interferon itself, antioxidants, α-tocopherol and vitamin C, as well as cocoa butter base, characterized in that it additionally contains hyaluronic acid and vitamin A, in the following weight ratios between components, g:
Recombinant human interferon alpha-2 - (7.0 - 17.5) • 10 6 IU
α-Tocopherol - 3.5 - 7.0
Vitamin C - 0.7 - 1.4
Vitamin A - 0.7 - 1.4
Hyaluronic Acid - 1.0 - 2.0
Cocoa Butter - Up to 100
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU97113248A RU2148988C1 (en) | 1997-07-21 | 1997-07-21 | Improved medicinal form of human interferon: suppository |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU97113248A RU2148988C1 (en) | 1997-07-21 | 1997-07-21 | Improved medicinal form of human interferon: suppository |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU97113248A true RU97113248A (en) | 1999-06-10 |
| RU2148988C1 RU2148988C1 (en) | 2000-05-20 |
Family
ID=20195944
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU97113248A RU2148988C1 (en) | 1997-07-21 | 1997-07-21 | Improved medicinal form of human interferon: suppository |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2148988C1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2674029C1 (en) * | 2017-08-24 | 2018-12-04 | Илья Александрович Марков | Rectal suppositories and method for preparation thereof (options) |
| RU2689320C1 (en) * | 2018-11-27 | 2019-05-27 | Илья Александрович Марков | Rectal suppository medicinal product and method for its preparation |
-
1997
- 1997-07-21 RU RU97113248A patent/RU2148988C1/en active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1097449A1 (en) | Methods for in vivo delivery of biologics and compositions useful therefor | |
| CA2093806A1 (en) | Method of treating or preventing type 1 diabetes by oral administration of insulin | |
| LV12766A (en) | Composition of l-dopa esters | |
| BR9907995A (en) | Immunological methods to modulate myostatin in vertebrate subjects | |
| YU61502A (en) | Nucleoside analogs with carboxamidine modified monocyclic base | |
| RU93047799A (en) | COMPOSITIONS CONTAINING RETAIC ACIDS AND TOKOFEROL | |
| DE60127457D1 (en) | FIBRATE STATIN COMBINES WITH REDUCED EFFECT ON THE FOOD RECEIPT | |
| IL74804A0 (en) | Human physiologically active polypeptide,its production and pharmaceutical compositions containing it | |
| EP0275005A3 (en) | Complex compounds of bioflavonoids with phospholipids, their preparation and use, and pharmaceutical and cosmetic compositions containing them | |
| ATE203415T1 (en) | ORAL ADMINISTRATION SYSTEM OF CHEMICALLY MODIFIED PROTEINS G-CSF | |
| CS545686A1 (en) | Farmaceuticky prostredek a antihepatotoxickym pusobenim | |
| IL81179A (en) | N-phenylbutenyl substituted azaheterocyclic carboxylic acids,their preparation and pharmaceutical compositions comprising them | |
| HUT46660A (en) | Process for producing 3-alkoxy-2-amino-propyl-amines and pharmaceutical compositions comprising the same as active ingredient | |
| RU97113248A (en) | IMPROVED MEDICINAL FORM OF HUMAN CANDLE INTERFERON | |
| CA2078869A1 (en) | Pharmaceutical compositions containing ipriflavone, process for the preparation thereof and relative therapeutic use | |
| CA2368767A1 (en) | Protease resistant flint analogs | |
| CA2429793A1 (en) | Interferon therapeutic effect enhancer | |
| MY104088A (en) | Peptide-drugs compositions containing (alpha)-aminoboroic acid derivatives. | |
| IT8520712A0 (en) | PHARMACEUTICAL FORMULATIONS TO STIMULATE THE RELEASE OF SOMATOTROPIC HORMONE. | |
| RU95121623A (en) | OINTMENT | |
| AU609435B2 (en) | Prevention of bovine respiratory disease complex in cattle by administration of interferon | |
| HUP0100634A2 (en) | Pharmaceutical preparations comprising pentaerytritol tetranitrate | |
| ZA941772B (en) | Treatment of mycobacterial diseases by administration of bactericidal/permeability-increasing protein products | |
| ITRM910038A1 (en) | PHARMACEUTICAL COMPOSITIONS HAVING CALCITONIN AS AN ACTIVE SUBSTANCE TO BE ADMINISTERED INTRANASALLY. | |
| IT8622051A0 (en) | PHARMACEUTICAL COMPOSITIONS HEALING ADAPTIVITY. |